<p>(A) Confocal laser microscopic observation of cells from mouse bone marrow 8 weeks after bone marrow replacement. Cells were observed under GFP fluorescence (a; green), DAPI nuclear staining (b; blue) and DIC (c) conditions, respectively. Merged images are shown accordingly (d). Scale bar = 20 µm. (B–C) Confocal laser microscopic observation of immunofluorescence labeled striatal sections 8 weeks after hBM-MSC transplantation in mice with QA−lesioned and bone marrow replacement. Bone marrow-derived cells labeled with GFP (a; green) were close to neuroblast cells (B-b; red) or internal neuron cells (C-b; red) in the striatum after hBM-MSC transplantation. TOTO3 signals (c; blue) represent the cell nuclei in the striatum. Corresponding mer...
<p>9-A: control group; 9-B: HUCBSCs group; 9-C: VCAM-1-HUCBSCs-1 group; 9-D: VCAM-1-HUCBSCs-2 group,...
<p>A, B: Photographs showing integrated MSCs in the brain. Integrated MSCs were mainly detected in t...
Cell replacement therapies for neurodegenerative diseases using stem cells require above all a good ...
<p>(A) Photomicrographs showing the presence of BrdU-labeled cells throughout the transplanted hemis...
<p>(A) Photomicrographs show the difference in striatal volumes in unilateral lesion mice. There was...
<p>Mosaic and magnified images longitudinally obtained from the calvarial bone marrow of the recipie...
<p><b>(a)</b> The numbers of B6 MHC class I KO or wild-type HSPCs in the skull BMs (2540 μm (x) × 25...
<p>(<b>A</b>) H&E staining of a normal brain 7 days following 3*2Gy radiation illustrates the locati...
<p>(A): Eight days after lesioning by injection of collagenase, B10 cells were transplanted. Two wee...
<p>Fluorescence microscopic analysis of EGFP-labeled rMSCs striatal sections in Lv-null-MSCs group a...
<p>Histology of transplanted H9-EF1-Luc2-GFP cells either labeled with <sup>19</sup>F (n = 4) (A) or...
<p>Representative photomicrograph illustrating that many transplanted cells survived in the striatum...
(a) Experimental design for the BMT experiment. The BMT mice were treated with 2 weeks of PLX5622 di...
The lack of effective treatments for neurodegenerative diseases prompted scientists to study stem ce...
(A) Schematic diagram depicting transplantation of CD34+ or CD34- McSCs, after labelling with fluore...
<p>9-A: control group; 9-B: HUCBSCs group; 9-C: VCAM-1-HUCBSCs-1 group; 9-D: VCAM-1-HUCBSCs-2 group,...
<p>A, B: Photographs showing integrated MSCs in the brain. Integrated MSCs were mainly detected in t...
Cell replacement therapies for neurodegenerative diseases using stem cells require above all a good ...
<p>(A) Photomicrographs showing the presence of BrdU-labeled cells throughout the transplanted hemis...
<p>(A) Photomicrographs show the difference in striatal volumes in unilateral lesion mice. There was...
<p>Mosaic and magnified images longitudinally obtained from the calvarial bone marrow of the recipie...
<p><b>(a)</b> The numbers of B6 MHC class I KO or wild-type HSPCs in the skull BMs (2540 μm (x) × 25...
<p>(<b>A</b>) H&E staining of a normal brain 7 days following 3*2Gy radiation illustrates the locati...
<p>(A): Eight days after lesioning by injection of collagenase, B10 cells were transplanted. Two wee...
<p>Fluorescence microscopic analysis of EGFP-labeled rMSCs striatal sections in Lv-null-MSCs group a...
<p>Histology of transplanted H9-EF1-Luc2-GFP cells either labeled with <sup>19</sup>F (n = 4) (A) or...
<p>Representative photomicrograph illustrating that many transplanted cells survived in the striatum...
(a) Experimental design for the BMT experiment. The BMT mice were treated with 2 weeks of PLX5622 di...
The lack of effective treatments for neurodegenerative diseases prompted scientists to study stem ce...
(A) Schematic diagram depicting transplantation of CD34+ or CD34- McSCs, after labelling with fluore...
<p>9-A: control group; 9-B: HUCBSCs group; 9-C: VCAM-1-HUCBSCs-1 group; 9-D: VCAM-1-HUCBSCs-2 group,...
<p>A, B: Photographs showing integrated MSCs in the brain. Integrated MSCs were mainly detected in t...
Cell replacement therapies for neurodegenerative diseases using stem cells require above all a good ...